Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. - Kottur J; White KM; Rodriguez ML; Rechkoblit O; Quintana-Feliciano R; Nayar A; García-Sastre A; Aggarwal AK (PLoS pathogens, 2023)